SCM
HAE icon

Semanteon Capital Management’s Haemonetics HAE Stock Holding History

Semanteon Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,798
Closed -$1.35M – 253
2024
Q1 		$1.35M Buy
+15,798
New +$1.24M 0.86% 2

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Semanteon Capital Management's HAE Position: Q2 2024 in Review

Semanteon Capital Management sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 15,798 shares — an estimated $1.35M sold.

Semanteon Capital Management first reported a position in HAE in Q1 2024 and held it in 1 quarter. The position peaked at $1.35M in Q1 2024. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Semanteon Capital Management reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Semanteon Capital Management sold 15,798 Haemonetics shares in Q2 2024, an estimated $1.35M.
  • Semanteon Capital Management first reported a position in Haemonetics in Q1 2024 and held it in 1 quarter.
  • Semanteon Capital Management's Haemonetics position peaked at $1.35M in Q1 2024.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Semanteon Capital Management's 13F filing for Q2 2024, filed 30 Jul 2024.